Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell CarcinomaBrandon J. Manley, A. Ari Hakimi, Emily C. Zabor et al.|European Urology Focus|2016Cited by 51
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell CarcinomaJozefina Casuscelli, A. Ari Hakimi, Christian G. Stief et al.|European Urology Focus|2017Cited by 46
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F. Becerra, James J. Hsieh, Ed Reznik et al.|European Urology Focus|2017Cited by 41
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, James J. Hsieh, Brandon J. Manley et al.|European Urology Focus|2016Cited by 36
Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutationsBrandon J. Manley, A. Ari Hakimi, Ed Reznik et al.|Urologic Oncology Seminars and Original Investigations|2017Cited by 28